Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Sees Significant Growth in Short Interest

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) was the target of a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 152,000 shares, an increase of 29.6% from the November 15th total of 117,300 shares. Based on an average daily volume of 148,600 shares, the short-interest ratio is presently 1.0 days. Currently, 0.9% of the company’s shares are short sold.

Inspira Technologies Oxy B.H.N. Price Performance

NASDAQ:IINN traded down $0.03 during trading hours on Friday, hitting $1.17. 107,172 shares of the company were exchanged, compared to its average volume of 417,584. The company has a quick ratio of 2.13, a current ratio of 2.23 and a debt-to-equity ratio of 0.09. Inspira Technologies Oxy B.H.N. has a one year low of $0.76 and a one year high of $2.49. The company has a fifty day simple moving average of $1.32 and a 200 day simple moving average of $1.33.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Inspira Technologies Oxy B.H.N. stock. Renaissance Technologies LLC acquired a new position in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 24,497 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned approximately 0.19% of Inspira Technologies Oxy B.H.N. at the end of the most recent quarter. Hedge funds and other institutional investors own 12.72% of the company’s stock.

Inspira Technologies Oxy B.H.N. Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.